0
JAMA 100 Years Ago | March 29, 1913|

THE RATTLESNAKE-VENOM TREATMENT OF EPILEPSY

JAMA. 2013;309(12):1207. doi:10.1001/jama.2012.145314.
Text Size: A A A
Published online

Extract

March 29, 1913

The fashion of using biologic products of extreme toxic potency is on us. It seems unnecessary to have these products accurately standardized, or to have their employment in human beings preceded by careful animal experimentation in which both the immediate and remote effects of such toxication can he determined. So long as a profound “reaction” is produced the end in view seems to have been attained, for by that reaction, if one may credit the enthusiastic reports of the advocates of these new and heroic therapeutic adventures, beneficial results in diseases otherwise practically incurable, epilepsy for instance, seem attainable. Curiously, however, these new fields for the employment of biologic toxins seem to require preliminary exploitation through the agency of the public press; and with the growing tendency of lay publications to magnify the sensational at the expense of the scientifically exact in alleged discoveries in medicine, there is little wonder that a treatment like the injection of rattlesnake-venom for epilepsy should have excited a lively and exaggerated interest.

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();